30
Views
30
CrossRef citations to date
0
Altmetric
Original article: Oncology

Endoglin (CD105) expression in head and neck basaloid squamous cell carcinoma

, , , , , & show all
Pages 307-311 | Received 04 Jun 2004, Accepted 29 Jul 2004, Published online: 08 Jul 2009

References

  • Paulino AFG, Singh B, Shah JP, Huvos AG. Basaloid squamous cell carcinoma of the head and neck. Laryngo-scope 2000;110:1479–82.
  • Colletta RD, Cotrim P, Almeida OP, Alves VAF, Wakamatsu A, Vargas PA. Basaloid squamous carcinoma of the oral cavity: a histologic and immunohistochemical study. Oral Oncol 2002;38:723–9.
  • Wain SL, Kier R, Vollmer RT, Bossen EH. Basaloid-squamous carcinoma of the tongue, hypopharynx and larynx: report of 10 cases. Hum Pathol 1986;17:1158–66.
  • Zbären P, Nuyensa M, Stauffer E. Basaloid squamous cell carcinoma of the hypopharynx. ORL J Otorhinolaryngol Relat Spec 2003;65:332–40.
  • Tanaka F, Ishikawa S, Yanagihara K, Miyahara R, Kawano Y, Li M, et al. Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res 2002; 62:7124–9.
  • Duff SE, Li C, Garland JM, Kumar S. CD105 is important for angiogenesis: evidence and potential applications. FASEB J 2003;17:984–92.
  • Pece Barbara N, Wrana JL, Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-13 superfamily. J Biol Chem 1999;274: 584–94.
  • International Union Against Cancer TNM classification of malignant tumours 5th ed. New York: Wiley-Liss; 1997.
  • Pesarin F. Multivariate permutation tests. Chichester, UK: Wiley; 2001.
  • Fonsatti E, Del Vecchio L, Altomonte M, Sigalotti L, Nicotra MR, Coral S, et al. Endoglin: an accessory component of the TGF-13-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. J Cell Physiol 2001;188:1–7.
  • Schimming R, Marme D. Endoglin (CD105) expression in squamous cell carcinoma of the oral cavity. Head Neck 2002;24:151–6.
  • Balza E, Castellani P, Zijlstra A, Neri D, Zardi L, Ski A. Lack of specificity of endoglin expression for tumor blood vessels. hit J Cancer 2001;94:579–85.
  • Takahashi N, Kawanishi-Tabata R, Haba A, Tabata M, Haruta Y, Tsai H, et al. Association of serum endoglin with metastasis in patients with colorectal, breast, and other solid tumors, and suppressive effect of chemotherapy on the serum endoglin. Chin Cancer Res 2001;7:524–32.
  • Fonsatti E, Altomonte M, Arslan P, Maio M. Endoglin (CD105): a target for anti-angiogenetic cancer therapy. Curr Drug Targets 2003;4:291–6.
  • Poetsch M, Lorenz G, Bankau A, Kleist B. Basaloid in contrast to nonbasaloid head and neck squamous cell carcinomas display aberrations especially in cell cycle control genes. Head Neck 2003;25:904–10.
  • Luna MA, El Naggar A, Parichatikanond P, Weber RS, Batsakis JG. Basaloid squamous carcinoma of the upper aerodigestive tract. Cancer 1990;66:537–42.
  • Banks ER, Frierson HF, Mills SE, George E, Zarbo RJ, Swanson PE. Basaloid squamous cell carcinoma of the head and neck. A clinicopathologic and immunohistochemical study of 40 cases. Am J Surg Pathol 1992;16:935–46.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.